Analyzing The EC's Drug Sector Inquiry Report

Law360, New York (July 29, 2009, 12:58 PM EDT) -- On July 8, 2009, the European Commission published its long-awaited final report on its inquiry into the pharmaceutical sector.

The final report lays out the commission’s factual findings on the state of competition in the EU pharmaceutical sector and identifies a number of areas where the regulatory framework may be influencing the entry of generic drugs.

The report echoes many of the findings from the commission’s preliminary report[1], although the commission has clearly retreated from its tone of criticism of the originator industry in that earlier...
To view the full article, register now.